Oncology Pharma Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Studies for Initial Phases of IND-Enabling Activities
31. März 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, March 31, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has provided the initial financing for the initiation of...
Oncology Pharma Reveals Strategic Plans for Company Growth and Focus
16. März 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) revealed today the Company’s plans for growth and development of its intellectual property...
Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy
10. März 2021 08:00 ET
|
Oncology Pharma, Inc.
San Francisco, CA, March 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH): Today, the company announced it is putting together a short list of contract research...
Oncology Pharma Moves to Fund Lead Drug Formulation & IND-Enabling Studies
04. März 2021 08:00 ET
|
Oncology Pharma, Inc.
San Francisco, CA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce initiation of formal drug development and preclinical planning for...
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
26. Februar 2021 08:00 ET
|
Oncology Pharma, Inc.
San Francisco, CA, Feb. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has executed a world-wide Licensing Agreement with Sybleu...
Oncology Pharma Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
22. Februar 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has extended a world-wide Licensing Agreement with NanoSmart...
Oncology Pharma is Pleased to Welcome New Chairman to Its Scientific Advisory Board
16. Februar 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that Dr. Henry Smith has accepted the role of Chairman of the...
Oncology Pharma Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform
09. Februar 2021 08:30 ET
|
Oncology Pharma, Inc.
San Francisco, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has renewed its world-wide Licensing Agreement with Ribera...
Oncology Pharma Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncology
03. Februar 2021 08:30 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has extended its Licensing Agreement with NanoSmart...
Oncology Pharma Announces the Appointment Of New Chief Financial Officer
28. Januar 2021 18:26 ET
|
Oncology Pharma, Inc.
San Francisco, CA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has retained the services of Mr. James Smith, CPA as its new...